Liposarcoma or lipoma: does genetics change classic imaging criteria?

Area of Science:

• Oncology
• Radiology
• Genetics

Background:

• Differentiating benign from malignant fatty tumors poses diagnostic challenges for radiologists and pathologists.
• Cytogenetic and molecular genetic analyses offer complementary tools for soft tissue tumor classification.

Purpose of the Study:

• To compare conventional imaging criteria for malignancy against a gold standard combining histopathology with cytogenetic and molecular genetic analyses.
• To evaluate the accuracy of imaging in diagnosing fatty tumors and identify potential pitfalls.

Main Methods:

• Nineteen patients with fatty tumors underwent computed tomography (CT) and/or magnetic resonance imaging (MRI).
• Histopathological, cytogenetic, and molecular genetic analyses were performed on all tumor samples.
• Imaging diagnoses were compared with the combined pathological and genetic findings.

Main Results:

• The imaging diagnosis correctly identified benign or malignant lesions in 15 out of 19 cases.
• Four cases were false positives for malignancy based on imaging criteria.
• Erroneous imaging criteria included large tumor size and non-purely fatty composition.

Conclusions:

• Large tumor size is a significant pitfall leading to false-positive radiological diagnoses of liposarcoma.
• Integrated pathological and genetic analyses provide a more definitive diagnostic standard.
• Cytogenetic and molecular genetic analyses can be effectively performed on core biopsy samples.